CPHI Podcast Series: the power of digital marketing in pharma
Digital marketing is a valuable tool for many industries, and the pharmaceutical and healthcare industry is no exception. The CPHI Podcast Series covers how marketing can be used by companies to increase their engagement and overcome challenges.
Digital Editor Lucy Chard is joined by Raman Sehgal, Founder of Ramarketing, talking about the use of marketing in sustainability, talent acquisition, and partnering.
Having founded several niche companies, Raman has grown ramarketing (headquartered in the UK’s North East with a presence in Boston, MA) beyond what he ever could have imagined. A multi-million dollar, PE-backed, specialist marketing agency in the life science space across the world to raise their profile and grow.
Raman is the co-founder of Lead Candidate, a specialist talent acquisition partner for the pharma and biotech outsourcing space, and a fellow podcaster, hosting industry-leading pharmaceutical podcast - Molecule to Market where he takes listeners inside the outsourcing space of the drug development and manufacturing ecosystem.
Outside of work, Raman is family-oriented. He is a happily married father of three boisterous boys. An active and sociable guy, Raman is a keen runner and a die-hard Newcastle United football fan.
Keen to share his knowledge, mistakes, and learnings in an honest manner, Raman is focused on helping others and is an active member of the business community. One of his favorite mottos is “sharing is caring, right?”, which is reflected in the impact that his work has on other businesses and individuals alike.
In this podcast the different ways marketing can help companies in achieving their goals are discussed, whether it’s in how to go about finding the right partner, creating the right messaging around a companies’ ESG values, or how to attract talent. We also go on to talk about the future of digital marketing, especially the increased use of AI in today’s world, how much this has changed everyday practices already, and how important marketing is for accelerating innovation in the industry today.
See the full podcast episode here.
Related News
-
News Understanding the Benefits and Advances of Cleanroom Technology
In an industry where precision and sterility are crucial concerns, cleanrooms play a vital role in maintaining the integrity of pharmaceutical products like drugs, vaccines, and other medical products. So, what is a cleanroom?
-
News AbbVie secures GBP£1.2 billion deal for Gilgamesh’s psychedelic programme
AbbVie has penned a significant agreement to acquire the bretisilocin programme from Gilgamesh Pharmaceuticals for up to £1.2 billion, marking a bold step in the pharmaceutical giant's quest to develop treatments for psychiatric disorders. -
News Gates Foundation commits US$2.5 billion to women’s health research
The Bill & Melinda Gates Foundation has announced a substantial US$2.5 billion commitment to accelerate research and development focused exclusively on women's health through 2030.
-
News Mid-year review: notable FDA drug approvals of 2025
As we fly past the halfway point of 2025, the pharmaceutical landscape reliably continues to evolve with innovative therapies addressing critical medical needs. The FDA has already approved 17 groundbreaking medications this year, each representin... -
News US FDA announces new priority vouchers for accelerated review times
The US FDA announced a new priority program for drug developers – the Commissioner’s National Priority Voucher (CNPV) program aims to enhance the health interests of the US by allowing drug developers to redeem a voucher, shortening th... -
News Google-backed start-up raises US$600 million to support AI drug discovery and design
London-based Isomorphic Labs, an AI-driven drug design and development start-up backed by Google’s AI research lab DeepMind, has raised US$600 million in its first external funding round by Thrive Capital. The funding will provide further power t... -
News AstraZeneca to invest US$2.5 billion in Beijing R&D centre
Amid investigations of former AstraZeneca China head Leon Wang in 2024, AstraZeneca have outlined plans to establish its sixth global strategic R&D centre in China. Their aim is to further advance life sciences in China with major research and manufact... -
News Experimental drug for managing aortic valve stenosis shows promise
The new small molecule drug ataciguat is garnering attention for its potential to manage aortic valve stenosis, which may prevent the need for surgery and significantly improve patient experience.